Evofem Biosciences (EVFM) Debt Ratio (2014 - 2026)
Evofem Biosciences' (EVFM) Debt Ratio was 0.05 for Q2 2026, up 80.7% from 0.03 a year earlier but down 98.9% from the prior quarter.
Analysis
Evofem Biosciences (EVFM) Debt Ratio (2014 - 2026) Analysis & Trends
For FY2025, Debt Ratio at Evofem Biosciences was 0.01, up 27.8% from FY2024.
- By year, Debt Ratio came in at 0.01 in FY2024 (-99.6%), 1.40 in FY2023 (-10.9%) and 1.57 in FY2022.
- Five-year quarterly Debt Ratio spans a low of 0.01 in Q4 2024 and a high of 6.65 in Q1 2024.
- Year over year, Debt Ratio has now increased in each of the last four quarters, with an average decline of 2.9% over the last eight quarters.
- The high point for year-over-year Debt Ratio in five years was Q1 2024 (growth of 627.3%); the low point was Q4 2024 (a decline of 99.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at 4.49 (Q1 2026), 0.01 (Q4 2025) and 0.02 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,176.80 Bn | 1,145.39 Bn | 19.71 Bn | 0.39 |
| 2 | Johnson & Johnson | 639.81 Bn | 558.34 Bn | 17.26 Bn | 0.24 |
| 3 | AbbVie | 503.28 Bn | 476.39 Bn | 12.70 Bn | 0.52 |
| 4 | Merck | 376.70 Bn | 331.08 Bn | 12.21 Bn | 0.42 |
| 5 | Novartis Ag | 303.61 Bn | 267.60 Bn | 11.24 Bn | 0.08 |
| 6 | Astrazeneca | 268.37 Bn | 242.05 Bn | 12.86 Bn | 0.28 |
| 7 | Amgen | 242.34 Bn | 197.74 Bn | 7.24 Bn | 0.60 |
| 8 | Gilead Sciences | 193.58 Bn | 167.78 Bn | 6.22 Bn | 0.53 |
| 9 | Pfizer | 172.88 Bn | 119.53 Bn | 10.94 Bn | 0.31 |
| 10 | Evofem Biosciences | 1.33 Mn | 1.33 Mn | 2.12 Mn | 0.05 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.05 |
| Mar 31, 2026 | 4.49 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | 0.03 |
| Mar 31, 2025 | 2.43 |
| Dec 31, 2024 | 0.01 |
| Sep 30, 2024 | 0.01 |
| Jun 30, 2024 | 0.05 |
| Mar 31, 2024 | 6.65 |
| Dec 31, 2023 | 1.40 |
| Sep 30, 2023 | 0.98 |
| Jun 30, 2023 | 1.11 |
| Mar 31, 2023 | 0.91 |
| Dec 31, 2022 | 2.46 |
| Sep 30, 2022 | 3.59 |
| Jun 30, 2022 | 0.50 |
| Mar 31, 2022 | 0.01 |
| Sep 30, 2021 | 1.02 |
| Jun 30, 2021 | 0.41 |
API Access
Evofem Biosciences Debt Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=debt-ratio&ticker=EVFM&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "debt-ratio", "ticker": "EVFM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=debt-ratio&ticker=EVFM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();